122 related articles for article (PubMed ID: 22938445)
1. Predictive potential of glutathione S-transferase polymorphisms for prognosis of osteosarcoma patients on chemotherapy.
Zhang SL; Mao NF; Sun JY; Shi ZC; Wang B; Sun YJ
Asian Pac J Cancer Prev; 2012; 13(6):2705-9. PubMed ID: 22938445
[TBL] [Abstract][Full Text] [Related]
2. Glutathione S-transferase polymorphisms and bone tumor risk in China.
Lu XF; Yang WL; Wan ZH; Li J; Bi ZG
Asian Pac J Cancer Prev; 2011; 12(12):3357-60. PubMed ID: 22471480
[TBL] [Abstract][Full Text] [Related]
3. The association of glutathione S-transferase polymorphisms in patients with osteosarcoma: evidence from a meta-analysis.
Wang Z; Xu H; He M; Wu H; Zhu Y; Su Z
Eur J Cancer Care (Engl); 2015 May; 24(3):417-24. PubMed ID: 24689813
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms in nucleotide excision repair pathway influences response to chemotherapy and overall survival in osteosarcoma.
Sun Y; Wu Y; Li W; Kong Z; Zou X
Int J Clin Exp Pathol; 2015; 8(7):7905-12. PubMed ID: 26339355
[TBL] [Abstract][Full Text] [Related]
5. Glutathione S-transferase P1 and DNA polymorphisms influence response to chemotherapy and prognosis of bone tumors.
Yang LM; Li XH; Bao CF
Asian Pac J Cancer Prev; 2012; 13(11):5883-6. PubMed ID: 23317281
[TBL] [Abstract][Full Text] [Related]
6. Predictive potential of ABCB1, ABCC3, and GSTP1 gene polymorphisms on osteosarcoma survival after chemotherapy.
Liu S; Yi Z; Ling M; Shi J; Qiu Y; Yang S
Tumour Biol; 2014 Oct; 35(10):9897-904. PubMed ID: 24996541
[TBL] [Abstract][Full Text] [Related]
7. Predictive role of GSTs on the prognosis of breast cancer patients with neoadjuvant chemotherapy.
Bai YL; Zhou B; Jing XY; Zhang B; Huo XQ; Ma C; He JM
Asian Pac J Cancer Prev; 2012; 13(10):5019-22. PubMed ID: 23244102
[TBL] [Abstract][Full Text] [Related]
8. Single nucleotide polymorphisms in the NER pathway and clinical outcome of patients with bone malignant tumors.
Sun XH; Hou WG; Zhao HX; Zhao YL; Ma C; Liu Y
Asian Pac J Cancer Prev; 2013; 14(3):2049-52. PubMed ID: 23679317
[TBL] [Abstract][Full Text] [Related]
9. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.
Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357
[TBL] [Abstract][Full Text] [Related]
10. Effect of variation of ABCB1 and GSTP1 on osteosarcoma survival after chemotherapy.
Li JZ; Tian ZQ; Jiang SN; Feng T
Genet Mol Res; 2014 Apr; 13(2):3186-92. PubMed ID: 24841650
[TBL] [Abstract][Full Text] [Related]
11. Association of GSTs gene polymorphisms with treatment outcome of advanced non-small cell lung cancer patients with cisplatin-based chemotherapy.
Wu G; Jiang B; Liu X; Shen Y; Yang S
Int J Clin Exp Pathol; 2015; 8(10):13346-52. PubMed ID: 26722539
[TBL] [Abstract][Full Text] [Related]
12. Clinical implications of glutathione S-transferase genotyping in patients with diffuse large B-cell lymphoma.
Atanaskovic L; Cikota-Aleksic B; Tarabar O; Trimcev J; Zivanovic-Ivic A; Marjanovic S; Magic Z
J BUON; 2016; 21(6):1459-1465. PubMed ID: 28039708
[TBL] [Abstract][Full Text] [Related]
13. Investigation on the DNA repaired gene polymorphisms and response to chemotherapy and overall survival of osteosarcoma.
Ji WP; He NB
Int J Clin Exp Pathol; 2015; 8(1):894-9. PubMed ID: 25755792
[TBL] [Abstract][Full Text] [Related]
14. Predictive impact of common variations in DNA repair genes on clinical outcome of osteosarcoma.
Bai SB; Chen HX; Bao YX; Luo X; Zhong JJ
Asian Pac J Cancer Prev; 2013; 14(6):3677-80. PubMed ID: 23886164
[TBL] [Abstract][Full Text] [Related]
15. Risk effects of GST gene polymorphisms in patients with acute myeloid leukemia: a prospective study.
Zhou L; Zhu YY; Zhang XD; Li Y; Liu ZG
Asian Pac J Cancer Prev; 2013; 14(6):3861-4. PubMed ID: 23886197
[TBL] [Abstract][Full Text] [Related]
16. Association of four ERCC1 and ERCC2 SNPs with survival of bone tumour patients.
Hao T; Feng W; Zhang J; Sun YJ; Wang G
Asian Pac J Cancer Prev; 2012; 13(8):3821-4. PubMed ID: 23098477
[TBL] [Abstract][Full Text] [Related]
17. [The effects of glutathione S-transferase (GSTT1 and GSTM1) genes polymorphisms on treatment efficacy and prognosis of acute myeloid leukemia].
Zhang Y; Yang L; Li R; Zhang L; Zhang MR; Xiao ZJ
Zhonghua Nei Ke Za Zhi; 2006 Mar; 45(3):213-6. PubMed ID: 16624155
[TBL] [Abstract][Full Text] [Related]
18. Single nucleotide polymorphism of hsa-miR-124a affects risk and prognosis of osteosarcoma.
Shi ZW; Wang JL; Zhao N; Guan Y; He W
Cancer Biomark; 2016 Jun; 17(2):249-57. PubMed ID: 27540978
[TBL] [Abstract][Full Text] [Related]
19. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.
Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T
Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358
[TBL] [Abstract][Full Text] [Related]
20. Predictive potential role of glutathione S-transferase polymorphisms in the prognosis of breast cancer.
Wang X; Huang ZH
Genet Mol Res; 2015 Aug; 14(3):10236-41. PubMed ID: 26345960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
